Navigation Links
AbbVie Reports Second-Quarter 2014 Financial Results
Date:7/25/2014

le asset amortization and other specified items.  The gross margin ratio under U.S. generally accepted accounting principles (GAAP) was 77.4 percent.  
  • Adjusted selling, general and administrative (SG&A) expense was 27.1 percent of sales in the second quarter, reflecting continued investment in our growth brands and the expected HCV launch.  On a GAAP basis, SG&A was 29.4 percent of sales.
  •  Adjusted research and development (R&D) was 16.1 percent of sales in the quarter, reflecting funding actions in support of our mid- and late-stage pipeline and the continued pursuit of additional HUMIRA indications.  On a GAAP basis, R&D was 16.9 percent of sales.
  • Net interest expense was $69 million, and the adjusted tax rate was 22.2 percent in the quarter. On a GAAP basis, the second-quarter tax rate was 23.4 percent.
  • Second-quarter diluted earnings per share were $0.68 on a GAAP basis.  Adjusted diluted earnings per share, excluding intangible asset amortization expense and other specified items, were $0.82.  
  • Key Events from the Second Quarter

  • AbbVie announced it reached an agreement with Shire's Board of Directors for a recommended transaction to combine the two companies.  The proposed combination is strategically compelling for both companies and will create a larger and more diversified biopharmaceutical company with multiple leading franchises.  The new company will also have significant financial capacity for future acquisitions, investment and enhanced shareholder distributions and value creation.
  • AbbVie announced the initiation of a Phase 3 clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with human epidermal growth factor receptor 2-(HER2) negative metastatic or locally-advanced breast cancer, con
    '/>"/>

  • SOURCE AbbVie
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine technology :

    1. AbbVie to Host Second-Quarter Earnings Conference Call
    2. AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
    3. AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
    4. AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
    5. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
    6. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
    7. AbbVie Reports Third-Quarter 2013 Financial Results
    8. AbbVie Named a Science Top Employer
    9. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
    10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
    11. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... ® , Inc. (NeuroSigma), a California -based ... of its Thin Film Nitinol (TFN) flow diverter were presented ... the 53 rd Annual Meeting of the American Society ... copy of the study abstract can be accessed via the ... Clinic was primarily funded through a Small Business Technology Transfer ...
    (Date:5/4/2015)... 4, 2015 According to a ... (Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope), Visualization Systems (Monitors, ... Laparoscopy, Arthroscopy) - Global Forecasts to 2019 ", published by ... $19.0 Billion by 2019 with a CAGR of around ... Browse   127   ma rket ...
    (Date:5/4/2015)... 4, 2015 Dynatronics Corporation (the "Company") ... of rehabilitation and physical therapy products, announced today ... raise approximately $4,000,000 in a private placement financing ... its affiliates (together with its affiliates, "Prettybrook"), a ... industry. The financing will provide Dynatronics with additional ...
    Breaking Medicine Technology:NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 4The Medical Videoscope Market Worth $19.0 Billion by 2019 2The Medical Videoscope Market Worth $19.0 Billion by 2019 3The Medical Videoscope Market Worth $19.0 Billion by 2019 4The Medical Videoscope Market Worth $19.0 Billion by 2019 5Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4
    (Date:5/4/2015)... 2015 “ Food Cost Calculator ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... to manage and efficiently calculate food costs. , The restaurant ... fact, the industry has an estimated 1.8 trillion dollar impact ...
    (Date:5/4/2015)... Today, Cireson reveals the following key announcements:, ... to strengthen core service & asset management solutions , ... Microsoft System Center and Cireson via Microsoft Azure in ... Company transitioning from a direct sales presence to 100% ... expanding new solutions for password reset management, gamification, self-service ...
    (Date:5/3/2015)... ANGELES, American Telemedicine Association 2015 Meeting & Tradeshow ... e-health solutions, a full-service telemedicine and mobile health ... new platform, VITA health services for chronic disease ... services platform enables remote patient monitoring of a ... heart failure (CHF), diabetes, COPD, hypertension and other ...
    (Date:5/3/2015)... Looking for a graduate business ... your career? The Master of International Business, executive ... multinational companies and for professionals seeking a career ... landscape, differences in culture, religion, government, and geography ... develops the global competence and confidence needed to ...
    (Date:5/2/2015)... As one of only 30 Illinois companies to be ... and Recognition Program (SHARP) certification, Essentra Specialty Tapes ... Department of Labor to host this special event. ... the Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation ... or exceed all of the necessary regulations and standards, ...
    Breaking Medicine News(10 mins):Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3
    ... NEW YORK, Sept. 3 Reportlinker.com announces that a new market research ... The Market for Minimally Invasive Medical Devices , ... This report: , , , ... medical device market , Forecasts trends and ...
    ... , , , , ... Reportlinker.com announces that a new market research report is available in ... Research Review , , http://www.reportlinker.com/p0128140/2008/2009-Healthcare-Research-Review.html ... that began in 2008 and continues into 2009, technology markets in ...
    ... NEW YORK, Sept. 3 Reportlinker.com announces that a new market research ... Botanical and Plant-Derived Drugs: Global Markets , ... , , This report: , , ... been commercialized to date , Contains forecasts ...
    ... Reportlinker.com announces that a new market research report is available ... Dental Market: Techniques, Equipment and Materials , , ... , INTRODUCTION , , STUDY ... report, The Dental Market: Techniques, Equipment, and Materials, provides an overview ...
    ... NEW YORK, Sept. 3 Reportlinker.com announces that a new market ... Commercial Amino Acids , , ... , STUDY OBJECTIVES , , This ... acids. Further, this study examines the current state of the commercial essential ...
    ... NEW YORK, Sept. 3 Reportlinker.com announces that a new ... , Markets for Advanced Wound Care ... , INTRODUCTION , , ... This updated BCC Research report provides an overview of advanced wound care ...
    Cached Medicine News:Health News:Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 2Health News:Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 3Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 2Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 3Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 4Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 5Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 6Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 7Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 8Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 9Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 10Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 11Health News:Reportlinker Adds 2008/2009 Healthcare Research Review Report 12Health News:Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report 2Health News:Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report 3Health News:Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report 4Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 2Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 3Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 4Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 5Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 6Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 7Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 8Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 9Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 10Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 11Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 12Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 13Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 14Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 15Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 16Health News:Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report 17Health News:Reportlinker Adds Commercial Amino Acids Report 2Health News:Reportlinker Adds Commercial Amino Acids Report 3Health News:Reportlinker Adds Commercial Amino Acids Report 4
    ... a comprehensive set of guidelines to ... systems (SDS) reagents and instrumentation. These ... follow. Many traditional variables, such as ... cycling protocol itself, have been standardized, ...
    ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
    Sealing tape featuring 3M adhesive technology. Repeat piercing with minimal residue. Not recommended for DMSO. Non-tacky to skin and gloves....
    Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
    Medicine Products: